Topics

Axonics® Announces Listing on the U.K.’s National Health Service Supply Chain for Its Sacral Neuromodulation System

08:00 EST 29 Nov 2018 | Businesswire
This article has expired, however you can still download the PDF.
Preview:
Axonics Modulation Technologies, Inc. (NASDAQ:AXNX), a medical technology company focused on the design, development and commercialization of innovative and minimally invasive sacral neuromodulation (“SNM”) solutions fo...

Other Sources for this Article

Axonics’ Contact
Axonics Modulation Technologies, Inc.
Dan Dearen, +1-949-396-6320
President & Chief Financial Officer
ir@axonics.com
Investor & Media Contact
W2Opure
Matt Clawson, +1-949-370-8500
mclawson@w2ogroup.com

NEXT ARTICLE

More From BioPortfolio on "Axonics® Announces Listing on the U.K.’s National Health Service Supply Chain for Its Sacral Neuromodulation System"

Quick Search

Relevant Topics

Urology
Benign Prostatic Hyperplasia (BPH) Erectile Dysfunction Urology Urology is the branch of medicine concerned with the urinary tract and diseases that affect it. Examples include urethritis, urethrostenosis and incontinence. Urology is a su...

Medical Devices
The role of medical devices in healthcare is essential.  The diversity and innovativeness of this sector contribute significantly to enhance the quality and efficacy of healthcare.  Covering a wide range of products, from simple bandages to the...